We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. More than one-quarter of patients with COVID-19 had ...

Please provide your email address to receive an email when new articles are posted on . Published results showed plasma D-dimer was noninferior to serum C-reactive protein and erythrocyte ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

Phase Ib study of drozitumab combined with cetuximab (CET) plus irinotecan (IRI) or with FOLFIRI with or without bevacizumab (BV) in previously treated patients (pts) with metastatic colorectal cancer ...

The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still spreading across many parts of the world, and clinicians are working on recognizing biomarkers ...

Feasibility of a prospective host cell reactivation assay (HCRA) in non-small cell lung cancer (NSCLC) patients. Background: Procoagulant changes in the haemostatic system and activation of ...

Tampa, FL (Oct. 26, 2021) --A screening blood test originally validated in seriously ill patients without COVID-19 is still clinically useful for ruling out pulmonary embolism in patients hospitalized ...

A video has flooded Facebook claiming that 62% of people given an mRNA vaccine for COVID-19 have developed blood clots. However, experts told Reuters there is no evidence of this. The clip was posted ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The plasma D-dimer assay has been used, along with clinical prediction scores, to rule out ...

Des Plaines, IL — A new study investigating D-dimer testing in patients who are at higher risk of pulmonary embolism (PE) has been published in the February issue of Academic Emergency Medicine (AEM), ...